Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'META-CHLOROPHENYLPIPERAZINE' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 182 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Baumann, MH; Ayestas, MA; Dersch, CM; Rothman, RB
      1-(m-chlorophenyl)piperazine (mCPP) dissociates in vivo serotonin release from long-term serotonin depletion in rat brain

      NEUROPSYCHOPHARMACOLOGY
    2. Erzegovesi, S; Martucci, L; Henin, M; Bellodi, L
      Low versus standard dose mCPP challenge in obsessive-compulsive patients

      NEUROPSYCHOPHARMACOLOGY
    3. Maes, M; van West, D; De Vos, N; Westenberg, H; Van Hunsel, F; Hendriks, D; Cosyns, P; Scharpe, S
      Lower baseline plasma cortisol and prolactin together with increased body temperature and higher mCPP-induced cortisol responses in men with pedophilia

      NEUROPSYCHOPHARMACOLOGY
    4. Houston, GC; Papadakis, NG; Carpenter, TA; Hall, LD; Mukherjee, B; James, MF; Huang, CLH
      Mapping of brain activation in response to pharmacological agents using fMRI in the rat

      MAGNETIC RESONANCE IMAGING
    5. Rainero, I; Valfre, W; Savi, L; Gentile, S; Pinessi, L; Gianotti, L; Arvat, E; Ghigo, E; Del Rizzo, P; Calvelli, P; Limone, P
      Neuroendocrine effects of subcutaneous sumatriptan in patients with migraine

      JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
    6. Tancer, ME; Johanson, CE
      The subjective effects of MDMA and mCPP in moderate MDMA users

      DRUG AND ALCOHOL DEPENDENCE
    7. Sher, L
      Possible genetic link between eating disorders and seasonal changes in mood and behavior

      MEDICAL HYPOTHESES
    8. Khanna, S; John, JP; Reddy, PL
      Neuroendocrine and behavioral responses to mCPP in obsessive-compulsive disorder

      PSYCHONEUROENDOCRINOLOGY
    9. Scheepers, FE; de Wied, CCG; Kahn, RS
      The effect of olanzapine treatment on m-chlorophenylpiperazine-induced hormone release in schizophrenia

      JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
    10. Maes, M; De Vos, N; Van Hunsel, F; Van West, D; Westenberg, H; Cosyns, P; Neels, H
      Pedophilia is accompanied by increased plasma concentrations of catecholamines, in particular epinephrine

      PSYCHIATRY RESEARCH
    11. Fritzsche, M; Heller, R; Hill, H; Kick, H
      Sleep deprivation as a predictor of response to light therapy in major depression

      JOURNAL OF AFFECTIVE DISORDERS
    12. Neumeister, A; Willeit, M; Praschak-Rieder, N; Asenbaum, S; Stastny, J; Hilger, E; Pirker, W; Konstantinidis, A; Kasper, S
      Dopamine transporter availability in symptomatic depressed patients with seasonal affective disorder and healthy controls

      PSYCHOLOGICAL MEDICINE
    13. Vassallo, CM; Feldman, E; Peto, T; Castell, L; Sharpley, AL; Cowen, PJ
      Decreased tryptophan availability but normal post-synaptic 5-HT2c receptorsensitivity in chronic fatigue syndrome

      PSYCHOLOGICAL MEDICINE
    14. Sher, L
      Genetic studies of seasonal affective disorder and seasonality

      COMPREHENSIVE PSYCHIATRY
    15. Steiger, H; Gauvin, L; Israel, M; Koerner, N; Kin, NMKNY; Paris, J; Young, SN
      Association of serotonin and cortisol indices with childhood abuse in bulimia nervosa

      ARCHIVES OF GENERAL PSYCHIATRY
    16. Broocks, A; Meyer, T; Gleiter, CH; Hillmer-Vogel, U; George, A; Bartmann, U; Bandelow, B
      Effect of aerobic exercise on behavioral and neuroendocrine responses to meta-chlorophenylpiperazine and to ipsapirone in untrained healthy subjects

      PSYCHOPHARMACOLOGY
    17. Laizure, SC; Cyr, M
      Nefazodone: An update

      INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE
    18. Monteleone, P
      Eating disorders and obsessive-compulsive disorder: phenomenological and biological similarities

      CURRENT OPINION IN PSYCHIATRY
    19. Berendsen, HHG
      The role of serotonin in hot flushes

      MATURITAS
    20. Pinessi, L; Rainero, I; Savi, L; Valfre, W; Limone, P; Calvelli, P; Del Rizzo, P; Gianotti, L; Taliano, M; Ghigo, E; Arvat, E
      Effects of subcutaneous sumatriptan on plasma growth hormone concentrations in migraine patients

      CEPHALALGIA
    21. Bardin, L; Lavarenne, J; Eschalier, A
      Serotonin receptor subtypes involved in the spinal antinociceptive effect of 5-HT in rats

      PAIN
    22. Heisler, LK; Tecott, LH
      A paradoxical locomotor response in serotonin 5-HT2C receptor mutant mice

      JOURNAL OF NEUROSCIENCE
    23. Broocks, A; Bandelow, B; George, A; Jestrabeck, C; Opitz, M; Bartmann, U; Gleiter, CH; Meineke, I; Roed, IS; Ruther, E; Hajak, G
      Increased psychological responses and divergent neuroendocrine responses to m-CPP and ipsapirone in patients with panic disorder

      INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
    24. Terao, T; Nakamura, J; Yoshimura, R; Ohmori, O; Takahashi, N; Shinkai, T
      Prediction of lithium response using m-chlorophenylpiperazine challenge test: a preliminary finding

      INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
    25. Stein, DJ
      Advances in the neurobiology of obsessive-compulsive disorder - Implications for conceptualizing putative obsessive-compulsive and spectrum disorders

      PSYCHIATRIC CLINICS OF NORTH AMERICA
    26. Terao, T; Nakamura, J; Yoshimura, R; Ohmori, O; Takahashi, N; Kojima, H; Soeda, S; Shinkai, T; Nakano, H; Okuno, T
      Relationship between serum cholesterol levels and meta-chlorophenylpiperazine-induced cortisol responses in healthy men and women

      PSYCHIATRY RESEARCH
    27. Ghaziuddin, N; King, CA; Welch, KB; Zaccagnini, J; Weidmer-Mikhail, E; Mellow, AM; Ghaziuddin, M; Greden, JF
      Serotonin dysregulation in adolescents with major depression: hormone response to meta-chlorophenylpiperazine (mCPP) infusion

      PSYCHIATRY RESEARCH
    28. Buydens-Branchey, L; Branchey, M; Hudson, J; Fergeson, P
      Low HDL cholesterol, aggression and altered central serotonergic activity

      PSYCHIATRY RESEARCH
    29. Lam, RW; Bowering, TA; Tam, EM; Grewal, A; Yatham, LN; Shiah, IS; Zis, AP
      Effects of rapid tryptophan depletion in patients with seasonal affective disorder in natural summer remission

      PSYCHOLOGICAL MEDICINE
    30. Kantor, S; Anheuer, ZE; Bagdy, G
      High social anxiety and low aggression in Fawn-Hooded rats

      PHYSIOLOGY & BEHAVIOR
    31. Leone, M; Attanasio, A; Croci, D; Filippini, G; D'Amico, D; Grazzi, L; Nespolo, A; Bussone, G
      The serotonergic agent m-chlorophenylpiperazine induces migraine attacks: A controlled study

      NEUROLOGY
    32. Wood, M; Chaubey, M; Atkinson, P; Thomas, DR
      Antagonist activity of meta-chlorophenylpiperazine and partial agonist activity of 8-OH-DPAT at the 5-HT7 receptor

      EUROPEAN JOURNAL OF PHARMACOLOGY
    33. Jung, ME; Wallis, CJ; Gatch, MB; Lal, H
      Sex differences in the discriminative stimulus effects of m-chlorophenylpiperazine and ethanol withdrawal

      PSYCHOPHARMACOLOGY
    34. Zulman, DM; Oren, DA
      Seasonal affective disorder

      CURRENT OPINION IN PSYCHIATRY
    35. Eriksson, E; Engberg, G; Bing, O; Nissbrandt, H
      Effects of mCPP on the extracellular concentrations of serotonin and dopamine in rat brain

      NEUROPSYCHOPHARMACOLOGY
    36. Broocks, A; Meyer, T; George, A; Hillmer-Vogel, U; Meyer, D; Bandelow, B; Hajak, G; Bartmann, U; Gleiter, CH; Ruther, E
      Decreased neuroendocrine responses to meta-chlorophenylpiperazine (m-CPP) but normal responses to ipsapirone in marathon runners

      NEUROPSYCHOPHARMACOLOGY
    37. Bancila, M; Verge, D; Rampin, O; Backstrom, JR; Sanders-Bush, E; McKenna, KE; Marson, L; Calas, A; Giuliano, F
      5-hydroxytryptamine(2C) receptors on spinal neurons controlling penile erection in the rat

      NEUROSCIENCE
    38. Wingrove, J; Bond, AJ; Cleare, AJ; Sherwood, R
      Trait hostility and prolactin response to tryptophan enhancement/depletion

      NEUROPSYCHOBIOLOGY
    39. Stein, DJ; Van Heerden, B; Wessels, CJ; Van Kradenburg, J; Warwick, J; Wasserman, HJ
      Single photon emission computed tomography of the brain with Tc-99m HMPAO during sumatriptan challenge in obsessive-compulsive disorder: Investigating the functional role of the serotonin auto-receptor

      PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
    40. Schwartz, PJ; Turner, EH; Garcia-Borreguero, D; Sedway, J; Vetticad, RG; Wehr, TA; Murphy, DL; Rosenthal, NE
      Serotonin hypothesis of winter depression: behavioral and neuroendocrine effects of the 5-HT1A receptor partial agonist ipsapirone in patients with seasonal affective disorder and healthy control subjects

      PSYCHIATRY RESEARCH
    41. Goddard, AW; Woods, SW; Money, R; Pande, AC; Charney, DS; Goodman, WK; Heninger, GR; Price, LH
      Effects of the CCKB antagonist CI-988 on responses to mCPP in generalized anxiety disorder

      PSYCHIATRY RESEARCH
    42. Sher, L; Goldman, D; Ozaki, N; Rosenthal, NE
      The role of genetic factors in the etiology of seasonal affective disorderand seasonality

      JOURNAL OF AFFECTIVE DISORDERS
    43. Levitan, RD; Jain, UR; Katzman, MA
      Seasonal affective symptoms in adults with residual attention-deficit hyperactivity disorder

      COMPREHENSIVE PSYCHIATRY
    44. McCann, UD; Eligulashvili, V; Mertl, M; Murphy, DL; Ricaurte, GA
      Altered neuroendocrine and behavioral responses to m-chlorophenylpiperazine in 3,4-methylenedioxymethamphetamine (MDMA) users

      PSYCHOPHARMACOLOGY
    45. von Moltke, LL; Greenblatt, DJ; Granda, BW; Grassi, JM; Schmider, J; Harmatz, JS; Shader, RI
      Nefazodone, meta-chlorophenylpiperazine, and their metabolites in vitro: cytochromes mediating transformation, and P450-3A4 inhibitory actions

      PSYCHOPHARMACOLOGY
    46. Cath, DC; Gijsman, HJ; Schoemaker, RC; van Griensven, JMT; Troost, N; van Kempen, GMJ; Cohen, AF
      The effect of m-CPP on tics and obsessive-compulsive phenomena in Gilles de la Tourette syndrome

      PSYCHOPHARMACOLOGY
    47. BHATARA VS; MAGNUS RD; PAUL KL; PRESKORN SH
      SEROTONIN SYNDROME INDUCED BY VENLAFAXINE AND FLUOXETINE - A CASE-STUDY IN POLYPHARMACY AND POTENTIAL PHARMACODYNAMIC AND PHARMACOKINETIC MECHANISMS

      The Annals of pharmacotherapy
    48. BUYDENSBRANCHEY L; BRANCHEY M; HUDSON J; ROTHMAN M; FERGESON P; MCKERNIN C
      EFFECT OF FENFLURAMINE CHALLENGE ON COCAINE CRAVING IN ADDICTED MALE USERS

      The American journal on addictions
    49. LEONE M; ATTANASIO A; CROCI D; FERRARIS A; DAMICO D; GRAZZI L; NESPOLO A; BUSSONE G
      5-HT1A RECEPTOR HYPERSENSITIVITY IN MIGRAINE IS SUGGESTED BY THE M-CHLOROPHENYLPIPERAZINE TEST

      NeuroReport
    50. SILBERSTEIN SD
      METHYSERGIDE

      Cephalalgia
    51. WALLIS CJ; LAL H
      A DISCRIMINATIVE STIMULUS PRODUCED BY 1-(3-CHLOROPHENYL)PIPERAZINE (MCPP) AS A PUTATIVE ANIMAL-MODEL OF ANXIETY

      Progress in neuro-psychopharmacology & biological psychiatry
    52. GOODNICK PJ; GOLDSTEIN BJ
      SELECTIVE SEROTONIN REUPTAKE INHIBITORS IN AFFECTIVE-DISORDERS - I - BASIC PHARMACOLOGY

      JOURNAL OF PSYCHOPHARMACOLOGY
    53. MOELLER FG; ALLEN T; CHEREK DR; DOUGHERTY DM; LANE S; SWANN AC
      IPSAPIRONE NEUROENDOCRINE CHALLENGE - RELATIONSHIP TO AGGRESSION AS MEASURED IN THE HUMAN LABORATORY

      Psychiatry research
    54. HOLLANDER E; KWON J; WEILLER F; COHEN L; STEIN DJ; DECARIA C; LIEBOWITZ M; SIMEON D
      SEROTONERGIC FUNCTION IN SOCIAL PHOBIA - COMPARISON TO NORMAL CONTROLAND OBSESSIVE-COMPULSIVE DISORDER SUBJECTS

      Psychiatry research
    55. BROOCKS A; PIGOTT TA; HILL JL; CANTER S; GRADY TA; LHEUREUX F; MURPHY DL
      ACUTE INTRAVENOUS ADMINISTRATION OF ONDANSETRON AND M-CPP, ALONE AND IN COMBINATION, IN PATIENTS WITH OBSESSIVE-COMPULSIVE DISORDER(OCD) - BEHAVIORAL AND BIOLOGICAL RESULTS

      Psychiatry research
    56. BOURIN M; BAKER GB; BRADWEJN J
      NEUROBIOLOGY OF PANIC DISORDER

      Journal of psychosomatic research
    57. KELLNER M; KNAUDT K; JAHN H; HOLSBOER F; WIEDEMANN K
      ATRIAL NATRIURETIC HORMONE IN LACTATE-INDUCED PANIC ATTACKS - MODE OFRELEASE AND ENDOCRINE AND PATHOPHYSIOLOGICAL CONSEQUENCES

      Journal of Psychiatric Research
    58. Issartel, V; Coudert, P; Rubat, C; Nhamias, S; Couquelet, J
      Synthesis of thiazolotriazine derivatives and their antinociceptive effects in mice

      JOURNAL OF PHARMACY AND PHARMACOLOGY
    59. FONE KCF; AUSTIN RH; TOPHAM IA; KENNETT GA; PUNHANI T
      EFFECT OF CHRONIC M-CPP ON LOCOMOTION, HYPOPHAGIA, PLASMA-CORTICOSTERONE AND 5-HT2C RECEPTOR LEVELS IN THE RAT

      British Journal of Pharmacology
    60. KAYE W; GENDALL K; STROBER M
      SEROTONIN NEURONAL FUNCTION AND SELECTIVE SEROTONIN REUPTAKE INHIBITOR TREATMENT IN ANOREXIA AND BULIMIA-NERVOSA

      Biological psychiatry
    61. PIAN KLH; WESTENBERG HGM; DENBOER JA; DEBRUIN WI; VANRIJK PP
      EFFECTS OF META-CHLOROPHENYLPIPERAZINE ON CEREBRAL BLOOD-FLOW IN OBSESSIVE-COMPULSIVE DISORDER AND CONTROLS

      Biological psychiatry
    62. ROTZINGER S; FANG J; COUTTS RT; BAKER GB
      HUMAN CYP2D6 AND METABOLISM OF M-CHLOROPHENYLPIPERAZINE

      Biological psychiatry
    63. BROOCKS A; LITTLE JT; MARTIN A; MINICHIELLO MD; DUBBERT B; MACK C; TUNE L; MURPHY DL; SUNDERLAND T
      THE INFLUENCE OF ONDANSETRON AND M-CHLOROPHENYLPIPERAZINE ON SCOPOLAMINE-INDUCED COGNITIVE, BEHAVIORAL, AND PHYSIOLOGICAL-RESPONSES IN YOUNG HEALTHY CONTROLS

      Biological psychiatry
    64. LEVITAN RD; KAPLAN AS; BROWN GM; VACCARINO FJ; KENNEDY SH; LEVITT AJ; JOFFE RT
      HORMONAL AND SUBJECTIVE RESPONSES TO INTRAVENOUS M-CHLOROPHENYLPIPERAZINE IN WOMEN WITH SEASONAL AFFECTIVE-DISORDER

      Archives of general psychiatry
    65. SCHWARTZ PJ; ROSENTHAL NE; WEHR TA
      SEROTONIN 1A RECEPTORS, MELATONIN, AND THE PROPORTIONAL CONTROL THERMOSTAT IN PATIENTS WITH WINTER DEPRESSION

      Archives of general psychiatry
    66. KAYE WH; GREENO CG; MOSS H; FERNSTROM J; FERNSTROM M; LILENFELD LR; WELTZIN TE; MANN JJ
      ALTERATIONS IN SEROTONIN ACTIVITY AND PSYCHIATRIC-SYMPTOMS AFTER RECOVERY FROM BULIMIA-NERVOSA

      Archives of general psychiatry
    67. Greenberg, DB; Benjamin, J; Martin, JD; Keuler, D; Huang, SJ; Altemus, M; Murphy, DL
      Delayed obsessive compulsive disorder symptom exacerbation after a single dose of a serotonin antagonist in fluoxetine-treated but not untreated patients

      PSYCHOPHARMACOLOGY
    68. GOMMANS J; HIJZEN TH; MAES RAA; OLIVIER B
      DISCRIMINATIVE STIMULUS PROPERTIES OF MCPP - EVIDENCE FOR A 5-HT2C RECEPTOR MODE OF ACTION

      Psychopharmacology
    69. BAGDY G; ARATO M
      GENDER-DEPENDENT DISSOCIATION BETWEEN OXYTOCIN BUT NOT ACTH, CORTISOLOR TSH RESPONSES TO M-CHLOROPHENYLPIPERAZINE IN HEALTHY-SUBJECTS

      Psychopharmacology
    70. BILKEIGORZO A; GYERTYAN I; LEVAY G
      MCPP-INDUCED ANXIETY IN THE LIGHT-DARK BOX IN RATS - A NEW METHOD FORSCREENING ANXIOLYTIC ACTIVITY

      Psychopharmacology
    71. GREENBERG BD; ALTEMUS M; MURPHY DL
      THE ROLE OF NEUROTRANSMITTERS AND NEUROHORMONES IN OBSESSIVE-COMPULSIVE DISORDER

      International review of psychiatry
    72. KOREEN AR; LIEBERMAN JA; ALVIR J; CHAKOS M
      THE BEHAVIORAL-EFFECT OF M-CHLOROPHENYLPIPERAZINE (MCPP) AND METHYLPHENIDATE IN FIRST-EPISODE SCHIZOPHRENIA AND NORMAL CONTROLS

      Neuropsychopharmacology
    73. SUNDERLAND T; MOLCHAN SE; LITTLE JT; BAHRO M; PUTNAM KT; WEINGARTNER H
      PHARMACOLOGICAL CHALLENGES IN ALZHEIMER-DISEASE AND NORMAL CONTROLS -COGNITIVE MODELING IN HUMANS

      Alzheimer disease and associated disorders
    74. STEIN DJ; BOUWER C
      A NEURO-EVOLUTIONARY APPROACH TO THE ANXIETY DISORDERS

      Journal of anxiety disorders
    75. LEONE M; ATTANASIO A; CROCI D; LIBRO G; GRAZZI L; DAMICO D; NESPOLO A; BUSSONE G
      THE M-CHLOROPHENYLPIPERAZINE TEST IN CLUSTER HEADACHE - A STUDY ON CENTRAL SEROTONINERGIC ACTIVITY

      Cephalalgia
    76. GOADSBY PJ
      HOW DO THE CURRENTLY USED PROPHYLACTIC AGENTS WORK IN MIGRAINE

      Cephalalgia
    77. ZHELYAZKOVASAVOVA M; GIOVANNINI MG; PEPEU G
      INCREASE OF CORTICAL ACETYLCHOLINE-RELEASE AFTER SYSTEMIC ADMINISTRATION OF CHLOROPHENYLPIPERAZINE IN THE RAT - AN IN-VIVO MICRODIALYSIS STUDY

      Neuroscience letters
    78. HOMMER D; ANDREASEN P; RIO D; WILLIAMS W; RUTTIMANN U; MOMENAN R; ZAMETKIN A; RAWLINGS R; LINNOILA M
      EFFECTS OF M-CHLOROPHENYLPIPERAZINE ON REGIONAL BRAIN GLUCOSE-UTILIZATION - A POSITRON EMISSION TOMOGRAPHIC COMPARISON OF ALCOHOLIC AND CONTROL SUBJECTS

      The Journal of neuroscience
    79. COCCARO EF; KAVOUSSI RJ; TRESTMAN RL; GABRIEL SM; COOPER TB; SIEVER LJ
      SEROTONIN FUNCTION IN HUMAN-SUBJECTS - INTERCORRELATIONS AMONG CENTRAL 5-HT INDEXES AND AGGRESSIVENESS

      Psychiatry research
    80. BUYDENSBRANCHEY L; BRANCHEY M; FERGESON P; HUDSON J; MCKERNIN C
      HORMONAL, PSYCHOLOGICAL, AND ALCOHOL CRAVING CHANGES AFTER M-CHLOROPHENYLPIPERAZINE ADMINISTRATION IN ALCOHOLICS

      Alcoholism, clinical and experimental research
    81. KENNETT GA; WOOD MD; BRIGHT F; TRAIL B; RILEY G; HOLLAND V; AVENELL KY; STEAN T; UPTON N; BROMIDGE S; FORBES IT; BROWN AM; MIDDLEMISS DN; BLACKBURN TP
      SB-242084, A SELECTIVE AND BRAIN PENETRANT 5-HT2C RECEPTOR ANTAGONIST

      Neuropharmacology
    82. BONHAUS DW; WEINHARDT KK; TAYLOR M; DESOUZA A; MCNEELEY PM; SZCZEPANSKI K; FONTANA DJ; TRINH J; ROCHA CL; DAWSON MW; FLIPPIN LA; EGLEN RM
      RS-102221 - A NOVEL HIGH-AFFINITY AND SELECTIVE, 5-HT2C RECEPTOR ANTAGONIST

      Neuropharmacology
    83. BENJAMIN J; NEMETZ H; FUX M; BLEICHMAN I; AGAM G
      ACUTE INOSITOL DOES NOT ATTENUATE M-CPP-INDUCED ANXIETY, MYDRIASIS AND ENDOCRINE EFFECTS IN PANIC DISORDER

      Journal of Psychiatric Research
    84. SU TP; SCHMIDT PJ; DANACEAU M; MURPHY DL; RUBINOW DR
      EFFECT OF MENSTRUAL-CYCLE PHASE ON NEUROENDOCRINE AND BEHAVIORAL-RESPONSES TO THE SEROTONIN AGONIST M-CHLOROPHENYLPIPERAZINE IN WOMEN WITH PREMENSTRUAL-SYNDROME AND CONTROLS

      The Journal of clinical endocrinology and metabolism
    85. MONTELEONE P; CATAPANO F; BORTOLOTTI F; MAJ M
      PLASMA PROLACTIN RESPONSE TO D-FENFLURAMINE IN OBSESSIVE-COMPULSIVE PATIENTS BEFORE AND AFTER FLUVOXAMINE TREATMENT

      Biological psychiatry
    86. LINDENMAYER JP; ADITYANJEE; VITALHERNE M; BARK N; GROCHOWSKI S; MOYNIHAN N
      HETEROGENEITY OF SEROTONERGIC RESPONSE IN TREATMENT-REFRACTORY SCHIZOPHRENIA-PATIENTS

      Biological psychiatry
    87. TERAO T; YOSHIMURA R; OHMORI O; TAKANO T; TAKAHASHI N; IWATA N; SUZUKI T; ABE K
      EFFECT OF SERUM-CHOLESTEROL LEVELS ON META-CHLOROPHENYLPIPERAZINE-EVOKED NEUROENDOCRINE RESPONSES IN HEALTHY-SUBJECTS

      Biological psychiatry
    88. LAWLOR BA; RADCLIFFE J; MARTINEZ R; SUNDERLAND T; MURPHY DL
      PLASMA-LEVELS OF M-CHLOROPHENYLPIPERAZINE FOLLOWING SINGLE ORAL DOSE ADMINISTRATION OF M-CHLOROPHENYLPIPERAZINE AND TRAZODONE IN HUMAN VOLUNTEERS

      Biological psychiatry
    89. SOUTHWICK SM; KRYSTAL JH; BREMNER JD; MORGAN CA; NICOLAOU AL; NAGY LM; JOHNSON DR; HENINGER GR; CHARNEY DS
      NORADRENERGIC AND SEROTONERGIC FUNCTION IN POSTTRAUMATIC-STRESS-DISORDER

      Archives of general psychiatry
    90. GEORGE DT; BENKELFAT C; RAWLINGS RR; ECKARDT MJ; PHILLIPS MJ; NUTT DJ; WYNNE D; MURPHY DL; LINNOILA M
      BEHAVIORAL AND NEUROENDOCRINE RESPONSES TO M-CHLOROPHENYLPIPERAZINE IN SUBTYPES OF ALCOHOLICS AND IN HEALTHY COMPARISON SUBJECTS

      The American journal of psychiatry
    91. QUESTED DJ; SARGENT PA; COWEN PJ
      SSRI TREATMENT DECREASES PROLACTIN AND HYPERTHERMIC RESPONSES TO MCPP

      Psychopharmacology
    92. SARGENT PA; SHARPLEY AL; WILLIAMS C; GOODALL EM; COWEN PJ
      5-HT2C RECEPTOR ACTIVATION DECREASES APPETITE AND BODY-WEIGHT IN OBESE SUBJECTS

      Psychopharmacology
    93. BROOCKS A; BRIGGS NC; PIGOTT TA; HILL JL; CANTER SK; TOLLIVER TJ; BALDEMORE D; MURPHY DL
      BEHAVIORAL, PHYSIOLOGICAL AND NEUROENDOCRINE RESPONSES IN HEALTHY-VOLUNTEERS TO M-CHLOROPHENYLPIPERAZINE (M-CPP) WITH AND WITHOUT ONDANSETRON PRETREATMENT

      Psychopharmacology
    94. JARRY JL; VACCARINO FJ
      EATING DISORDER AND OBSESSIVE-COMPULSIVE DISORDER - NEUROCHEMICAL ANDPHENOMENOLOGICAL COMMONALITIES

      Journal of psychiatry & neuroscience
    95. HOLLANDER E; WONG CM
      THE RELATIONSHIP BETWEEN EXECUTIVE FUNCTION IMPAIRMENT AND SEROTONERGIC SENSITIVITY IN OBSESSIVE-COMPULSIVE DISORDER

      Neuropsychiatry, neuropsychology, and behavioral neurology
    96. BREWERTON TD; JIMERSON DC
      STUDIES OF SEROTONIN FUNCTION IN ANOREXIA-NERVOSA

      Psychiatry research
    97. MAES M; VANDOOLAEGHE E; DESNYDER R
      EFFICACY OF TREATMENT WITH TRAZODONE IN COMBINATION WITH PINDOLOL OR FLUOXETINE IN MAJOR DEPRESSION

      Journal of affective disorders
    98. LUCKI I
      SEROTONIN RECEPTOR SPECIFICITY IN ANXIETY DISORDERS

      The Journal of clinical psychiatry
    99. ADITYANJEE; PANDURANGI A; LINDENMAYER JP; JAMPALA VC
      M-CPP CHALLENGE TEST AS PREDICTOR OF RESPONSE TO CLOZAPINE IN SCHIZOPHRENIA

      Psychiatric annals
    100. COWEN PJ; CLIFFORD EM; WALSH AES; WILLIAMS C; FAIRBURN CG
      MODERATE DIETING CAUSES 5-HT2C RECEPTOR SUPERSENSITIVITY

      Psychological medicine


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 12/08/20 alle ore 15:18:15